POGZ (1q21.3, OMIM#614787) pathogenic variants are associated with hypotonia, dysmorphisms, microcephaly, developmental delay, ASD and epilepsy in 20% of patients.42 In Patient 9, the POGZ variant was associated with moderate intellectual disability and drug-resistant EMAtS. Here, POGZ is linked to epilepsy.